These tended to be older than non-CKD patients (median age at diagnoses, 72 versus 64 years, p < 0.05) and had more often elevated B2M plasma levels > 3.5 mg/L (44.1% versus 10.6%, p < 0.001). This evidence concerns the gene B2M and chronic kidney disease.